<DOC>
	<DOCNO>NCT01300312</DOCNO>
	<brief_summary>The purpose study investigate effect fix dose combination diclofenac eperisone hydrochloride compare plain eperisone hydrochloride patient low back pain .</brief_summary>
	<brief_title>A Clinical Trial Study Effects Fixed Dose Combination Diclofenac Eperisone Hydrochloride With Plain Eperisone Hydrochloride Patients With Low Back Pain</brief_title>
	<detailed_description>This study observer-blind , prospective randomize , control study evaluate efficacy safety fix dose combination eperisone hydrochloride 50 mg diclofenac sodium 50 mg three time daily plain eperisone hydrochloride 50 mg three time daily patient musculoskeletal spasm associate low back pain . A total 240 adult patient either sex , 120 patient arm , fulfill inclusion exclusion criterion include study . The patient evaluate Days 3 , 7 10 study visit efficacy safety . The efficacy evaluation include objective parameter like Finger-to-Floor distance , Lasegue 's sign , tenderness par vertebral muscle , lumbar dorsal hypermyotonia , leg tendon reflex , need rescue medication subjective parameter like improvement lumbar cinesalgia , pain low extremity , sensory disturbance low limb , Global Assessment Response Therapy ( PGART ) . Patients evaluate safety clinical adverse event report study period , sedation drowsy alert scale Global Assessment Tolerability Therapy ( PGATT ) . The patient also evaluate laboratory safety assess measure laboratory parameter hemogram , renal hepatic parameter .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Spasm</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Eperisone</mesh_term>
	<criteria>Patient either sex 18 60 year age Patients confirm diagnosis Acute Musculoskeletal spasm Low Back Pain due follow cause : 1 . Spondylosis deformans 2 . Prolapsed Intervertebral Disc ( PID ) 3 . Muscle Sprains spasms Patients willing take medication direct willing come followup Willing comply protocol requirement Willing give write informed consent Patients associate lumbar spinal tract condition spondylitis , fracture , cancer , severe arthritis osteoporosis . Muscular disease myositis , poliomyelitis , muscular dystrophy myotonia . Other known systemic disease affect neurological endocrine . Patients moderate severe hepatic impairment ( defined increase serum bilirubin , serum glutamic oxaloacetic transaminase ( SGOT ) serum glutamic pyruvic transaminase ( SGPT ) &gt; 2.5 time upper reference level laboratory value ) renal impairment ( defined increase serum creatinine Blood urea nitrogen &gt; 2.5 time upper reference level laboratory value ) . Patients take form skeletal muscle relaxant previous 7 day . Pregnant / Lactating woman woman child bear potential follow adequate contraceptive measure . Patients know hypersensitivity ingredient study/active comparators . Patients previous history current episode cardiovascular disorder . Subject know follow disorder : renal failure , bulimia , hypo hyperthyroidism , nephrotic syndrome , anorexia nervosa , biliary obstruction , severe cardiac dysfunction . Uncontrolled diabetes mellitus metabolic disorder . Pediatric pregnant patient . Patients history alcoholic/substance abuse . Treatment investigational drug precede 4 week . Patients active recent history , inflammatory disease gastrointestinal tract peptic ulcer , gastritis , regional enteritis , ulcerative colitis . Patients acetylsalicylic acid ( ASA ) nonsteroidal antiinflammatory agent ( NSAIDs ) induce asthma , rhinitis , urticaria allergic manifestation . Any condition , opinion investigator , justify inclusion subject study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>eperisone</keyword>
	<keyword>diclofenac</keyword>
	<keyword>low back pain</keyword>
</DOC>